Literature DB >> 19376270

Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study.

Anna Doab1, Libby Topp, Carolyn A Day, Gregory J Dore, Lisa Maher.   

Abstract

This pilot study examined knowledge, understanding and perceived acceptability of key methodological concepts in clinical trials among injecting drug users (IDUs) in Sydney, Australia. Participants were clinical trial-experienced (n = 17) and trial-naïve (n = 99) IDUs recruited from community needle and syringe programs, and through institutions involved in clinical trials with IDU participants. Cross-sectional data were collected via a study-specific interviewer-administered survey. Following detailed verbal explanations, higher proportions of trial-experienced than trial-naïve participants demonstrated an understanding of all clinical trial concepts assessed, including single blinding (94% versus 60%); placebo (94% versus 49%); equipoise (71% versus 60%); comparison (59% versus 46%); randomisation (59% versus 21%); and double blinding (47% versus 3%). Multivariate analyses indicated a better understanding among trial-experienced participants. Participants who demonstrated an understanding of 'placebo' and 'double blinding' were significantly more likely to perceive these concepts to be acceptable than those who did not. Results indicate the need for targeted education programs that adequately inform IDUs about clinical trial concepts prior to recruitment to a clinical trial, and support adaptations of informed consent procedures to ensure trial participants' comprehensive understanding of methodologies and their implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376270     DOI: 10.1016/j.cct.2009.04.002

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  5 in total

Review 1.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

2.  Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.

Authors:  April M Young; Dustin B Stephens; Hanan A Khaleel; Jennifer R Havens
Journal:  Contemp Clin Trials       Date:  2014-12-30       Impact factor: 2.226

3.  Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.

Authors:  Sasha Uhlmann; Michael John Milloy; Keith Ahamad; Paul Nguyen; Thomas Kerr; Evan Wood; Lindsey Richardson
Journal:  Am J Addict       Date:  2015-03-24

4.  Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.

Authors:  Joanne Neale; Charlotte N E Tompkins; Rebecca McDonald; John Strang
Journal:  Addiction       Date:  2018-02-21       Impact factor: 6.526

5.  Participants' Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical Research.

Authors:  Geoff Bardwell; Kaitlyn Jaffe; P Todd Korthuis; Lindsey Richardson
Journal:  J Addict Med       Date:  2021 Sep-Oct 01       Impact factor: 3.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.